Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation
PAFOS
1 other identifier
interventional
249
1 country
1
Brief Summary
Evaluation of dynamic Atrial Overdrive Stimulation using the AF Suppression Algorithm to prevent atrial tachyarrhythmias in patients with more than 2% Auto Mode Switch Episodes with optimized pacemaker programming. Hypothesis: Dynamic atrial Overdrive (AF Suppression) reduces AT/AF Burden by 30% as compared to programming DDDR-(60) without AF Suppression when all other parameters are optimized.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2002
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 26, 2013
CompletedFirst Posted
Study publicly available on registry
July 31, 2013
CompletedOctober 8, 2024
October 1, 2024
5.5 years
July 26, 2013
October 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of AT/AF Burden in the pacemaker diagnostics
12 months
Study Arms (2)
AF Suppression On
ACTIVE COMPARATORAF Suppression Algorithm On, optimized AF Pacemaker Programming
AF Suppression Off
ACTIVE COMPARATORAF Suppression programmed Off, Optimized Pacemaker Programming
Interventions
Implantation of a dual chamber pacemaker
Eligibility Criteria
You may qualify if:
- indication for dual chamber pacemaker
- documented paroxysmal or persistent Atrial Fibrillation
- P-wave \>1.0 mV in Sinus Rhythm or sufficient detection of AFib
- stable antyarrhythmic therapy
- age \>= 19 years
- written informed consent
- implantation of a Identity DR 5370/5376 or later
- bipolar atrial lead
You may not qualify if:
- permanent AFib
- reversible etiology of AFib
- HYHA II or IV
- Coronary Artery disease with stable angina pectoris
- implanted ICD or planned implantation of a ICD
- cardiac surgery within the last 6 months or planned within 12 months
- live expectancy \< 12 months
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitätsklinikum Bonn AdöR
Bonn, 53127, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2013
First Posted
July 31, 2013
Study Start
July 1, 2002
Primary Completion
January 1, 2008
Study Completion
April 1, 2008
Last Updated
October 8, 2024
Record last verified: 2024-10